Certara stock.

Mar 22, 2023 · Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55. 48 Salaries (for 28 job titles) • Updated 13 Oct 2023. How much do Certara employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people share salaries on ...Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.19,104 units of CERT stock worth $411,691 on 5 June 2023.

Exhibit 10.21 . CERTARA, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN . 1. Purpose.The purpose of the Plan is to provide a means by which Eligible Employees may purchase Common Stock, thereby strengthening their commitment to the welfare of the Company and its Designated Companies and aligning their interests with those of the …November 17, 2021. PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.5,746 units of CERT stock worth $437,730 on 27 February 2018.

Find the latest Oshkosh Corporation (OSK) stock quote, history, news and other vital information to help you with your stock trading and investing.Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent …

The estimated Net Worth of William F Feehery is at least $78.7 Millón dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Feb 2, 2022 · Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ... Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free RegistrationThe estimated Net Worth of Leif E Pedersen is at least $5.76 million dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $2,900,831 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

The estimated Net Worth of Leif E Pedersen is at least $5.68 Million dollars as of 22 November 2022. Mr Pedersen owns over 51,223 units of Certara stock worth over $2,820,285 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.

Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.

Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.Contact Us U.S. markets open in 9 hours 29 minutes S&P Futures 4,574.25 -2.50(-0.05%) Dow Futures 36,033.00 +23.00(+0.06%) Nasdaq Futures 15,955.50 -30.00(-0.19%) …Certara Inc CERT:US Nasdaq GS (USD) Delayed price as of 2:59 PM EST 11/21/23. Market open. 14.45 –0.27 –1.80% Prev. close 14.71 USD 14.45 USD 3:00 PM …... stock price by the number of shares outstanding. Certara market cap as of December 01, 2023 is $2.34B. Compare CERT With Other Stocks. Sector, Industry, Market ...Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued.

According to 7 stock analysts, the average 12-month stock price forecast for Certara stock is $50.29, which predicts an increase of 240.60%. The lowest target is $16 and the highest is $235. On average, analysts rate Certara stock as a buy.ETF Watch. Macquarie Introduces Its First U.S. ETFs. Gabe Alpert | Nov 30, 2023. Our CERT ETF report shows the ETFs with the most CERT exposure, the top performing CERT ETFs, and most popular CERT ... Legal Name Certara, Inc. Stock Symbol NASDAQ:CERT. Company Type For Profit. Contact Email [email protected]. Phone Number 415-237-8272. Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include …Nov 27, 2022 · ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ... Certara recently reported its Q4 2022 financial results, beating revenue and EPS consensus estimates. Read more to know why I rate CERT stock as a hold.

Certara Inc’s stock is NA in 2023, NA in the previous five trading days and up 17.38% in the past year. Currently, Certara Inc’s price-earnings ratio is 112.4. Certara Inc’s trailing 12-month revenue is $352.1 million with a 5.4% net profit margin. Year-over-year quarterly sales growth most recently was 9.3%.Certara's software platform Simcyp group awarded two new grants from US FDA Certara downgraded at Jefferies on growth headwinds Certara Non-GAAP EPS of $0.12 misses by $0.01, revenue of $90.45M ...

If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Download Version 8.4. Reach Your Professional Development Goals. Certara University provides on-demand and on-site courses. Our programs are designed for novice and advanced users in the area of pharmacokinetic (PK) and pharmacodynamics (PD) and are taught using Certara software including the industry-standard software Phoenix …According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis. Nov 24, 2023 · See the latest Certara Inc Ordinary Shares stock price (700:XBER), related news, valuation, dividends and more to help you make your investing decisions. ETF Watch. Macquarie Introduces Its First U.S. ETFs. Gabe Alpert | Nov 30, 2023. Our CERT ETF report shows the ETFs with the most CERT exposure, the top performing CERT ETFs, and most popular CERT ... Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, …

Find the latest Udemy, Inc. (UDMY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 10, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 10, 2023, 4:00 PM, CST, Certara Inc’s stock price was $13.50. Certara Inc is up 6.72% from its previous closing price of $12.65. During the last market session, Certara Inc’s stock traded between $12.61 and $13.36. Currently, there are 159.17 million shares of Certara Inc stock ...

Certara is a former municipality in the district of Lugano in the canton of Ticino in Switzerland. On 14 April 2013 the former municipalities of Bogno, Cadro, Carona, Certara, Cimadera, Valcolla and Sonvico merged into the municipality of Lugano. History.Legal Name Certara, Inc. Stock Symbol NASDAQ:CERT. Company Type For Profit. Contact Email [email protected]. Phone Number 415-237-8272. Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include …Dec 1, 2023 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ... If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Certara, Inc. (CERT) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.01 per share a year ago.Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Certara, Inc.'s business for stockholders, potential investors, and financial analysts.Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%.According to the issued ratings of 15 analysts in the last year, the consensus rating for Devon Energy stock is Moderate Buy based on the current 6 hold ratings, 8 buy ratings and 1 strong buy rating for DVN. The average twelve-month price prediction for Devon Energy is $57.82 with a high price target of $77.00 and a low price target of $48.00.A Barchart Premier membership lets you screen on these options using advanced filters, including strategies for Covered Calls, Naked Puts and Option Spreads ...

Real time Certara (CERT) stock price quote, stock graph, news & analysis.Nov 27, 2022 · ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ... Nov 23, 2023 · Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%. Instagram:https://instagram. carson wealth omahawhat is a lean on a homeviewwcurrent mortgage rates phoenix az Nov 29, 2023 · Certara, Inc. Stock price Equities CERT US15687V1098 Software Market Closed - Nasdaq ... The estimated Net Worth of Richard M. Traynor is at least $10.2 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,562,422 and over the last 2 years he sold CERT stock worth over $5,603,360. forex trading signal servicedividends calendar 0.68%. $788.96M. Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full … eose energy SOLO | Complete Electrameccanica Vehicles Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.While strong estimate revisions for Certara, Inc. have attracted decent investments and pushed the stock 13.2% higher over the past four weeks, further upside may still be left in the stock.